Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$5.07M Sell
118,317
-39,629
-25% -$1.78M ﹤0.01% 2017
2014
Q2
$7.95M Buy
157,946
+9,792
+7% +$452K 0.01% 1547
2014
Q1
$6.53M Sell
148,154
-39,745
-21% -$1.89M 0.01% 1603
2013
Q4
$7.64M Sell
187,899
-36,335
-16% -$1.34M 0.01% 1486
2013
Q3
$7.54M Sell
224,234
-29,059
-11% -$946K 0.01% 1352
2013
Q2
$7.26M Buy
+253,293
New +$7.38M 0.01% 1283

Other funds holding ALKS

UBS's ALKS Position: Q3 2014 in Review

UBS reduced its Alkermes (ALKS) stake by 25% in Q3 2014, selling an estimated $1.78M and leaving 118,317 shares worth $5.07M. The position accounts for ﹤0.01% of the portfolio, ranked #2017.

UBS first reported a position in ALKS in Q2 2013 and has held it in 6 quarters since. The position peaked at $7.95M in Q2 2014. 205 funds tracked by Wall St. Rank hold ALKS as of Q3 2014.

  • UBS held 118,317 shares of Alkermes worth $5.07M as of Q3 2014.
  • UBS sold 39,629 Alkermes shares in Q3 2014, an estimated $1.78M.
  • Alkermes made up ﹤0.01% of UBS's portfolio in Q3 2014, its #2017 holding.
  • UBS first reported a position in Alkermes in Q2 2013 and has held it in 6 quarters since.
  • UBS's Alkermes position peaked at $7.95M in Q2 2014.
  • 205 funds tracked by Wall St. Rank held Alkermes as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.